Amphastar Pharmaceuticals (AMPH) vs Avalyn Pharma (AVLN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Avalyn Pharma is the larger company by market cap ($1.13 billion vs $1.09 billion), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | AMPH | AVLN |
|---|---|---|
| Share price | $25.54 | $25.53 |
| Market cap | $1.09B | $1.13B |
| 1-day change | -1.43% | +0.39% |
| YTD return | -4.63% | — |
| 1-year return | -1.12% | — |
| 5-year return | +33.65% | — |
| P/E ratio (TTM) | 15.11 | — |
| Forward P/E | 8.03 | — |
| EPS (TTM) | $1.69 | $-2.47 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $29.52 | $40.17 |
| 52-week low | $16.65 | $24.15 |
| Distance from 52-week high | -13.48% | -36.45% |
| Average volume | 467.34K | 238.20K |
| Shares outstanding | 42.54M | 44.33M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
AMPH vs AVLN FAQ
Which is bigger, Amphastar Pharmaceuticals or Avalyn Pharma?
Avalyn Pharma (AVLN) is larger, with a market capitalization of $1.13B compared with $1.09B for Amphastar Pharmaceuticals (AMPH).
Are Amphastar Pharmaceuticals and Avalyn Pharma in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.